Poseida Therapeutics
Focus: Poseida Therapeutics is a San Diego-based biotech focused on genome editing and CAR-T cell therapies for oncology and neurology indications. The company operates as a clinical-stage developer with a diversified pipeline spanning multiple myeloma, lymphoma, breast cancer, and prostate cancer.
Profile data last refreshed 51m ago · AI intelligence enriched 3w ago
Open Jobs
0
About Poseida Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Poseida Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Poseida Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
7 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
P-BCMA-ALLO1 CAR-T cells
Multiple MyelomaP-CD19CD20-ALLO1 Cells
Multiple SclerosisP-CD19CD20-ALLO1
Help build intelligence for Poseida Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.